Cargando…

Inflammatory activity and vitamin D levels in an MS population treated with rituximab

BACKGROUND: Most multiple sclerosis patients on disease-modifying treatment at Umeå University Hospital are treated with rituximab and the prevalence of vitamin D supplementation has increased over time. Follow-up studies of these off-label treatments are needed. OBJECTIVE: To study inflammatory act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Linden, Johan, Granåsen, Gabriel, Salzer, Jonatan, Svenningsson, Anders, Sundström, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378455/ https://www.ncbi.nlm.nih.gov/pubmed/30800416 http://dx.doi.org/10.1177/2055217319826598

Ejemplares similares

Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy
por: Salzer, Jonatan, et al.
Publicado: (2016)

Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis
por: Boremalm, Malin, et al.
Publicado: (2021)

Improved working ability in a contemporary MS population compared with a historic non-treated MS population in the same geographic area of Sweden
por: Wickström, Anne, et al.
Publicado: (2015)

Brain Parenchymal Fraction in Healthy Adults—A Systematic Review of the Literature
por: Vågberg, Mattias, et al.
Publicado: (2017)

Effectiveness of care in acute dizziness presentations
por: Sandlund, Mikael Granberg, et al.
Publicado: (2019)

Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension
por: Bergman, Joakim, et al.
Publicado: (2020)

Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS
por: Bergman, Joakim, et al.
Publicado: (2020)

Free vitamin D(3) index and vitamin D‐binding protein in multiple sclerosis: A presymptomatic case–control study
por: Grut, Viktor, et al.
Publicado: (2022)

COVID‐19 clinical outcomes and DMT of MS patients and population‐based controls
por: Longinetti, Elisa, et al.
Publicado: (2022)

Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controls
por: de Flon, Pierre, et al.
Publicado: (2018)

Rituximab, MS, and pregnancy
por: Smith, Jessica B., et al.
Publicado: (2020)

Association of vitamin D status and clinical and radiological outcomes in a treated MS population in Poland
por: Wawrzyniak, Sławomir, et al.
Publicado: (2016)

Low-dose rituximab should be used for treating MS in resource-limited settings: No
por: Mateen, Farrah J
Publicado: (2022)

Low-dose rituximab should be used for treating MS in resource-limited settings: Yes
por: Piehl, Fredrik, et al.
Publicado: (2022)

Remote testing of vitamin D levels across the UK MS population—A case control study
por: Vickaryous, Nicola, et al.
Publicado: (2020)

Increased Circulating Levels of Vitamin D Binding Protein in MS Patients
por: Rinaldi, Arturo Ottavio, et al.
Publicado: (2015)

Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally
por: Svenningsson, Anders, et al.
Publicado: (2015)

Vitamin D levels in an Australian population
por: Gill, Tiffany K, et al.
Publicado: (2014)

Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis
por: Burman, Joachim, et al.
Publicado: (2023)

The Magic Triangle in Oral Potentially Malignant Disorders: Vitamin D, Vitamin D Receptor, and Malignancy
por: Khamis, Aya, et al.
Publicado: (2023)

Quantitative determination of vitamin D metabolites in plasma using UHPLC-MS/MS
por: Ding, Shujing, et al.
Publicado: (2010)

Normative video head impulse test data in subjects with and without vascular risk factors
por: Hansson, Anders, et al.
Publicado: (2020)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
por: Boyer-Suavet, Sonia, et al.
Publicado: (2020)

DIET AND NUTRITION: Vitamin D Regulates MS Gene
por: Potera, Carol
Publicado: (2009)

Vitamin D enhances responses to interferon-β in MS
por: Feng, Xuan, et al.
Publicado: (2019)

The Role of Vitamin D in Patients with Inflammatory Bowel Disease Treated with Vedolizumab
por: Abraham, Bincy P., et al.
Publicado: (2023)

Internet-based vestibular rehabilitation versus standard care after acute onset vertigo: a study protocol for a randomized controlled trial
por: Surano, Solmaz, et al.
Publicado: (2022)

Quantification and reporting of vitamin D concentrations measured in human milk by LC–MS/MS
por: Jones, Kerry S., et al.
Publicado: (2023)

Development of anti-rituximab antibodies in rituximab-treated patients: Related parameters & consequences
por: Saffari, Fatemeh, et al.
Publicado: (2022)

10 years of 25-hydroxyvitamin-D testing by LC-MS/MS-trends in vitamin-D deficiency and sufficiency
por: Galior, Kornelia, et al.
Publicado: (2018)

Vitamin D supplementation and serum neurofilament light chain in interferon‐beta‐1b‐treated MS patients
por: Hänninen, Katariina, et al.
Publicado: (2020)

Determination of vitamin D status in singleton and twin gestations using CLIA and LC-MS/MS
por: Zgliczyńska, Magdalena, et al.
Publicado: (2023)

Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
por: Thiel, Jens, et al.
Publicado: (2013)

Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma
por: Millet, Aurélien, et al.
Publicado: (2021)

Association between levels of vitamin D and inflammatory markers in healthy women
por: Azizieh, Fawaz, et al.
Publicado: (2016)

Impact of Vitamin D Supplementation on Inflammatory Markers’ Levels in Obese Patients
por: Wiciński, Michał, et al.
Publicado: (2021)

Lower vitamin D levels are associated with the pathogenesis of inflammatory bowel diseases
por: Topalova-Dimitrova, Antonia, et al.
Publicado: (2023)

Comparison of follicular T helper cells, monocytes, and T cells priming between newly diagnosed and rituximab-treated MS patients and healthy controls
por: Yahyazadeh, Sheida, et al.
Publicado: (2022)

Vitamin D and inflammatory diseases
por: Yin, Kai, et al.
Publicado: (2014)

Vitamin D in inflammatory diseases
por: Wöbke, Thea K., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hjc4l1j8mm5q2t5n73kn9p151t